Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review

G Stemer, R Lemmens-Gruber - BMC nephrology, 2011 - Springer
Background Chronic kidney disease (CKD) and end-stage renal disease (ESRD) represent
worldwide health problems with an epidemic extent. Therefore, attention must be given to …

[HTML][HTML] Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

GR Matzke, GR Aronoff, AJ Atkinson Jr, WM Bennett… - Kidney international, 2011 - Elsevier
Drug dosage adjustment for patients with acute or chronic kidney disease is an accepted
standard of practice. The challenge is how to accurately estimate a patient's kidney function …

A quantitative approach to drug dosing in chronic kidney disease

AJ Olyaei, JL Steffl - Blood purification, 2011 - karger.com
Chronic kidney disease (CKD) is increasing at an alarming rate. Medication prescribing in
this growing population is especially difficult. Many pharmacological agents or their …

Paediatric drug development: are population models predictive of pharmacokinetics across paediatric populations?

M Cella, W Zhao, E Jacqz‐Aigrain… - British journal of …, 2011 - Wiley Online Library
WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT• In paediatric development, initial
estimation of the paediatric dose is obtained by extrapolation. This is usually performed …

The effect of critical illness on drug distribution

D Gonzalez, DJ Conrado… - Current …, 2011 - ingentaconnect.com
The complexity of managing critically ill patients has increased since the early establishment
of intensive care units in the 1950s. Despite of the fact that the number of drugs available to …

Psychische Störungen bei somatischen Krankheiten

HP Kapfhammer - … Psychotherapie: Band 1: Allgemeine Psychiatrie, Band …, 2011 - Springer
Psychische Störungen bei somatischen Krankheiten definieren einen Kernsektor der
psychosomatischen Medizin. Kognitive wie affektive Veränderungen können gleichermaßen …

Management of hematological malignancies in patients affected by renal failure

P Niscola, G Vischini, A Tendas… - Expert review of …, 2011 - Taylor & Francis
The management of hematological malignancies (HM) in renally impaired patients may be a
difficult task. Indeed, the kidney represents a major elimination pathway for many …

Influence of renal impairment on the pharmacokinetics of oral roflumilast: an open-label, parallel-group, single-center study.

TD Bethke, M Hartmann, A Hünnemeyer… - … Journal of Clinical …, 2011 - europepmc.org
Objective Roflumilast is a novel, orally active, selective phosphodiesterase 4 inhibitor
recently approved in the European Union for the treatment of severe COPD. Roflumilast and …

[PDF][PDF] Prevalence of impaired renal function in the elderly in the St. Petersburg District: results of the Crystal study

G Van Pottelbergh, C Van Pottelbergh… - Advances in …, 2011 - lirias.kuleuven.be
Chronic kidney disease (CKD) has a high prevalence in the elderly. It has been recognized
as an independent cardiovascular risk factor and detecting CKD is also important to ensure …

Use of recalibrated serum creatinine concentrations for adjustment of drug dosages: determination of values compatible with conventional dosing recommendations

MA Jones, LK Golightly… - Annals of …, 2011 - journals.sagepub.com
BACKGROUND: Measurement of serum creatinine concentration is central to evaluation of
kidney function. Recent efforts to increase the accuracy of this evaluation have led to …